Omarigliptin
id:
omarigliptin-175-18193051
title:
Omarigliptin
text:
Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. It inhibits DPP-4 to increase incretin levels, which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Omarigliptin
date created:
2015-09-20T14:41:15Z
date modified:
2024-09-03T13:08:46Z
main entity:
{"identifier":"Q21098979","url":"https://www.wikidata.org/entity/Q21098979"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/cd/Omarigliptin.svg","width":512,"height":199}
fields total:
13
integrity:
16